Drug Target Review

JANUARY 12, 2024

This one size fits all approach to drug prescribing still pervades in mostly all therapy areas except oncology. Therefore, having biomarker information is useful for separating individuals and ensuring that you treat an individual as an individual and can tailor their therapy. Most drugs do not work in all people.

Doctors 110

Doctors Clinical Trials Treatment Therapies 110

The Pharma Data

OCTOBER 22, 2020

22, 2020 — Kids with autism or attention-deficit hyperactivity disorder ( ADHD ) go to the hospital more in their first year of life than children without these conditions, according to a new study. Children with ADHD had more blood transfusions, hospital admissions and emergency department visits. THURSDAY, Oct.

Hospitals 52

Hospitals Doctors Science Research 52

biobide

FEBRUARY 2, 2024

Children and adolescents lack robust preclinical models to replicate the pathologies and provide precise and targeted therapies. This is why not many Pharma companies specifically specialize in discovering and developing pediatric cancer treatments; a great example of advancing new therapies for childhood cancer is the biotech Oncoheroes.

Disease 59

Disease Medical Schools Pharma Companies Clinical Trials 59

The Pharma Data

NOVEMBER 20, 2020

20, 2020 — Hormone therapy can be a lifesaver for men with prostate cancer , but it also appears to put some at increased risk of heart problems, a new study reports. ” Doctors treating prostate cancer patients with poor heart health need to be vigilant regarding heart-related side effects of ADT, said Dr. . FRIDAY, Nov.

Therapies 52

Therapies Doctors Disease Hospitals 52

Drug Target Review

JANUARY 23, 2024

Cell-based therapies, such as tumour-infiltrating lymphocyte (TIL) therapy, have also drawn significant attention following promising results in a melanoma trial. About the author Dr Espen Basmo Ellingsen University of Oslo Dr Ellingsen is a Medical Doctor and holds a PhD in cancer immunology from the University of Oslo.

Treatment 121

Treatment Immune Response Vaccine Therapies 121

On Medicine

MAY 11, 2023

There are a few (but growing) centers that will proactively see patients with diabetes in high-risk areas when admitted to the hospital, however, by far the most common practice is for patients to only be seen by a specialist team, including for diabetes, on receipt of a referral.

Nurses 52

Nurses Research Doctors Hospitals 52

Broad Institute

JANUARY 25, 2024

The study also provides insight into the genes and biological pathways that determine retinal health, which could be leveraged to develop future therapies, the researchers say. Altogether, the team identified 259 genetic loci that were associated with retinal thickness. Paper cited Zekavat SM, Doroodgar Jorshery S, et al.

Disease 125

Disease Research Medical Schools Science 125

Drug Target Review

DECEMBER 28, 2023

In most cancers, the tumour evolves by acquiring mutations that confer growth advantages or resistance to therapies. Involving more than 250 investigators based at 19 hospital sites across the UK, the study has analysed genetic signatures in lung tumours, tracking how they have evolved over the past nine years in more than 815 patients.

Bioinformatics 104

Bioinformatics Immune Response DNA Vaccine 104

Drug Target Review

FEBRUARY 26, 2024

Regarding therapy resistant melanomas, why is the alteration of the epigenetic landscape considered significant, and what has been lacking in terms of validated targetable epigenetic mechanisms? What is remarkable here is that we show that the addition of corin to BRAFi-resistant tumour cells resensitises them to BRAFi therapies.

Therapies 58

Therapies Molecular Biology Regulations Medical Schools 58

Perficient: Drug Development

JUNE 26, 2023

Manage referrals : Receive a referral and apply an AI model to review referral data and determine the correct doctor or other component of the referral. Support Operations With Deep Learning (DL) Insights Delays in hospital throughput have negative impacts on financial and hospital optimization results.

Nurses 52

Nurses Doctors Hospitals Engineering 52

Drug Target Review

JUNE 17, 2024

I was very pleased to be heavily involved with one of the very first radiopharmaceutical therapy programs for patients with neuroendocrine tumours (NETs) nearly two decades ago. Could you share an example of a specific project or research that you have worked on and the impact it has had in your field? The opportunities are truly enormous.

Science 58

Science Therapies International Hospitals 58

The Pharma Data

NOVEMBER 25, 2020

When Lawnae arrived at the hospital an hour and a half later, the left side of her body had gone limp. Doctors said they weren’t equipped to treat stroke patients. Nearly 10 hours after the onset of the stroke, Lawnae arrived at a Florida hospital. Doctors there removed four centimeters of her damaged trachea.

Doctors 52

Doctors Hospitals Therapies Treatment 52

The Pharma Data

JANUARY 21, 2021

It requires a long hospital stay, plus a period of months when patients are severely immunocompromised, Bebo said. The trick, according to Rae-Grant, is to strike a balance: Doctors would not want to be overly aggressive in using stem cell transplants, but would also want to intervene early enough to forestall disability as much as possible.

Therapies 52

Therapies Clinical Trials Doctors Trials 52

Olympian Clinical Research

OCTOBER 14, 2021

The more participants there are, the easier it will be for researchers and doctors to determine what works and what doesn’t work in real world conditions. When you join a clinical trial, you’ll be assigned to a team of doctors and researchers who will monitor your health very closely. You’ll Get Great Medical Care.

Clinical Trials 52

Clinical Trials Trials Doctors Therapies 52

FDA Law Blog: Biosimilars

OCTOBER 10, 2023

Beitz earned a Bachelor of Arts (summa cum laude and honors in chemistry) from Barnard College, Columbia University, and a Doctor of Medicine from the College of Physicians and Surgeons, Columbia University.

FDA 49

FDA Drugs Drug Development Doctors 49

Drug Discovery World

APRIL 14, 2023

He is being recognised for his revolutionary contributions to developing the first gene-edited cell-based therapy for cancer that involves the genetic re-engineering of a patient’s own T cells to combat their disease, and for demonstrating that adoptive T-cell therapy can induce remission and in some cases cure patients with advanced cancer.

Clinical Trials 130

Clinical Trials Research Science Clinical Research 130

The Pharma Data

JANUARY 15, 2021

He’s director of the Advanced Lung Disease and Lung Transplant Program at Inova Fairfax Hospital in Falls Church, Va. The study period was short, however, (16 weeks) and it’s unclear what the long-term effects would be, including whether the therapy can help extend patients’ lives. © 2021 HealthDay. Source link.

Disease 52

Disease Doctors FDA Approval Trials 52

PPD

MAY 18, 2023

The care partners are the decision-makers for their loved ones with neurodegenerative disorders, handling everything from daily routines and medication management to doctor visits. Another extension of this is to have trial sites located in a hospital, where the person with dementia already routinely visits. Non-drug therapies.

Clinical Trials 86

Clinical Trials Trials Clinical Research Doctors 86

Drug Discovery World

JULY 29, 2022

Isselbacher Professor of Medicine in the Field of Gastroenterology at Harvard Medical School and Massachusetts General Hospital, a core institute member at the Broad Institute of MIT and Harvard, and co-director of the Center for Microbiome Informatics and Therapeutics at MIT. Study after study had suggested that A. Funding and authorship.

Research 130

Research Immune Response Medical Schools Disease 130

The Pharma Data

JANUARY 17, 2021

The treatment could be administered in primary care centers to people who test positive for COVID-19, avoiding hospitalization due to the progression of the disease and complementing the vaccine in the early phase after vaccination. BARCELONA, Spain , Jan. 18, 2021 /PRNewswire/ — Grifols (MCE: GRF, MCE: GRF.P,

Clinical Trials 52

Clinical Trials Treatment Trials Hospitals 52

The Pharma Data

NOVEMBER 3, 2020

But, in some patients, COVID-19 appears to damage the nerve that regulates speech, causing their vocal cords to impede breathing even when they aren’t talking, said Dr. Jonathan Aviv, an ear, nose and throat specialist at Mount Sinai Hospital in New York City. “Think about when you’re chit-chatting.

Doctors 52

Doctors Therapies Virus Hospitals 52

The Pharma Data

FEBRUARY 1, 2021

By getting what is known as a ‘high tibial osteotomy,’ younger patients with less severe joint damage who are physically active might be able to delay the need for a knee replacement by 10 years or more, though they may have to search for a doctor who performs the surgery. “Ask your doctor, “Would this be right for me?

Doctors 52

Doctors Disease Hospitals Research 52

The Pharma Data

DECEMBER 3, 2020

There are ways of increasing — or decreasing — therapy if needed, but Rizzo said doctors need to be aware of new approaches to treatment and be attuned to how their patients are feeling and coping with the condition. Elevated levels of nitric oxide can determine whether a patient might need more or different therapy.

Doctors 52

Doctors Treatment Therapies Disease 52

The Pharma Data

JANUARY 6, 2021

. “In our cases, we think that tumors arose from mother-to-infant vaginal transmission through aspiration of tumor-contaminated vaginal fluids during birth,” said lead researcher Dr. Ayumu Arakawa, a pediatric oncologist with the National Cancer Center Hospital in Tokyo. The findings were reported Jan.

Vaccine 52

Vaccine Doctors Hospitals Virus 52

Drug Discovery World

JUNE 5, 2023

She said: “It’s not so much about proving the technology, but it’s more about demonstrating how we take it towards the patient space.

Small Molecule 130

Small Molecule Treatment Science Disease 130

Drug Channels

NOVEMBER 24, 2020

My recent tweets have highlighted: doctors against step therapy, distribution of COVID-19 therapies, biosimilar savings, copay accumulator data, prospects for smaller PBMs, the new transparency rule, specialty pharmacy profit metrics, the future of oncology practices, and an update on Diplomat founder Phil Hagerman.

Pharmacy 52

Pharmacy Specialty Pharmacies Biosimilars Doctors 52

The Pharma Data

JANUARY 27, 2021

Yet insurance does not cover the therapy for stroke patients. That’s partly because after a stroke, the emphasis is often on rehab for any disabilities a patient might have, said Elizabeth Regan, a clinical assistant professor of physical therapy at the University of South Carolina, in Columbia. 27, 2021, online.

Medical Schools 52

Medical Schools Hospitals Therapies Doctors 52

The Pharma Data

DECEMBER 10, 2020

The next thing Sandi remembers, it was a week later and she was in the hospital. To alleviate pressure from a burst blood vessel, doctors had shaved her head and removed part of her skull. She spent weeks undergoing physical, occupational and speech therapy. A tight helmet protected her head until doctors replaced her skull.

Nurses 52

Nurses Doctors Hospitals Therapies 52

The Pharma Data

SEPTEMBER 1, 2021

With a goal of developing rheumatoid arthritis therapies with minimal side effects, researchers at Washington University School of Medicine in St. The research team’s ultimate aim is to develop therapies for people coping with rheumatoid arthritis, a debilitating condition that affects about 1.3 million adults in the United States.

Engineering 52

Engineering Drugs Doctors Therapies 52

Drug Discovery World

OCTOBER 18, 2022

For example, the University of Basel works very closely with partners from both the academic world and industry, and in 1996, it jointly founded the Neuroscience Network Basel along with the University Hospital, the Friedrich Miescher Institute and the local pharmaceutical industry. He has worked for F.

International 130

International Engineering Science Pharmaceuticals 130

The Pharma Data

NOVEMBER 17, 2020

It’s a minimally invasive procedure in which doctors use heat or cold to destroy bits of heart tissue that are generating the faulty electrical signal causing the arrhythmia. And only 11% of ablation patients had an episode that caused symptoms — compared with 26% of those on drug therapy.

Doctors 52

Doctors Trials Clinical Trials Treatment 52

The Pharma Data

JUNE 1, 2022

With more than two decades of biopharmaceutical R&D experience, Dr. Anderson most recently served as Vice President and Chief Scientific Officer for Bacterial Research and Hospital within the Vaccine R&D organization.

Vaccine 40

Vaccine Research Doctors Laboratories 40

Codon

FEBRUARY 13, 2024

Tom Ireland writes about the companies and technologies that are reimagining phage therapy. Soon after its publication, scientists, journalists, and investors were revisiting ‘phage therapy’ as a promising alternative to our failing antibiotics. Read it on our website here. Illustration by David S. Fast forward to 2023.

Therapies 138

Therapies DNA Virus Clinical Trials 138

The Pharma Data

FEBRUARY 12, 2022

Doctors call this drug ‘bari,’ and receiving the pill once a day for up to 14 days yielded one of the largest a survival advantages seen yet in the COVID pandemic, according to a study published in The Lancet Respiratory Medicine. Source link: [link].

Hospitals 40

Hospitals Clinical Trials Licensing Licensing 40

The Pharma Data

FEBRUARY 12, 2022

The team’s findings are also supported by an analysis of patient data by Rita Seeböck from the University Hospital St. To optimize therapy for their patients, doctors are already analyzing the expression of certain genes. Patient data supports findings. Pölten, Austria.

Doctors 40

Doctors Research Hospitals Therapies 40

The Pharma Data

JANUARY 20, 2021

The approval of Verquvo by the FDA, which is the first treatment for chronic heart failure approved specifically for patients following a hospitalization for heart failure or need for outpatient IV diuretics, is based on the results of the pivotal Phase 3 VICTORIA trial and follows a priority regulatory review. Verquvo (vericiguat) 2.5

FDA Approval 52

FDA Approval FDA Hospitals Treatment 52

The Pharma Data

MAY 15, 2021

If You or Someone You Love is Suffering From Chronic Fatigue Syndrome, Then This Will Be the Most Important Letter You Will Ever Read… “Doctors Told Me There Was No Cure For Chronic Fatigue Syndrome…But Contrary To Their Prediction, I Got My Life Back From My CFS…100% Naturally! Description: ATTENTION!

Doctors 52

Doctors Production Therapies Treatment 52